STOCK TITAN

Xeriant announces First Major LOI for Retacell®-based Wall Panels and additional Building Materials, with potential value at over $250 Million

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Xeriant, Inc. (OTCQB: XERI) has signed a significant Letter of Intent with Next New Concept to supply up to $130 million worth of Retacell®-based wall panels for a 35,000-unit residential project in Africa. This initiative could potentially generate over $250 million in revenue for Xeriant starting in 2023. Retacell® is recognized for its biodegradable and nontoxic properties, providing thermal and fire protection. CEO Keith Duffy highlighted the deal as a major milestone, affirming its role in establishing a solid foundation for other agreements.

Positive
  • Signed LOI with Next New Concept for $130 million in wall panels.
  • Potential revenue generation of over $250 million starting in 2023.
  • Retacell® is biodegradable and nontoxic, enhancing product appeal.
Negative
  • None.

BOCA RATON, Fla., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI) (“Xeriant” or “the Company”), a company dedicated to the discovery and development of advanced materials and technology, recently signed its first major Letter of Intent (“LOI”) with Next New Concept (“NNC”) for the purchase of up to $130 million of Xeriant’s Retacell®-based wall panels, for a 35,000-unit residential development project in Africa, anticipated to be completed within five years.

NNC has now expressed interest in acquiring additional building products through Xeriant, including doors coated with Retacell®-infused paint. The project between NNC and Xeriant could now generate more than $250 million in revenue for Xeriant beginning in 2023. NNC is an innovator in environmentally friendly, quickly constructed building systems for affordable quality housing.

“Advancing the Next New Concept agreement marks a key milestone for Xeriant and is a major step forward for our Retacell®-based wall panels. This project will not only open up new opportunities for our wall panels, it will help us establish a solid foundation for some of the other agreements that we’ve been working on,” stated Keith Duffy, CEO of Xeriant.

Retacell® is a biodegradable and nontoxic high-performance thermal- and fire-protection chemical agent that is custom formulated to meet each application’s specifications and can be applied as a coating or treatment or infused during manufacturing into a variety of materials, including recycled plastics and wood-based fiber. Retacell®-infused materials are also water repellent.

About Next New Concept, Inc.

Next New Concept, Inc. (NNC™ branded) is a vertically integrated design, marketing, manufacturing, and sub-contractor construction company launching its patent pending, whole house alternative to wood frame construction. NNC™ teams deliver, assemble, and construct each new building envelope on build-ready slabs or foundations, serving as the SINGLE SOURCE product manufacturer and SINGLE SOURCE framing and insulation subcontractor. The NNC WHOLE HOUSE SOLUTION includes panelized exterior insulated walls, interior walls, trusses, and insulated roof deck; based on the Company’s patent pending structural aluminum building system.

For more information, please go to www.nextnewconcept.com

About Xeriant, Inc.

Xeriant, Inc. is a holding and operating company dedicated to the discovery and development of advanced materials and technology related to next generation air and spacecraft, which can be successfully integrated and commercialized for deployment across multiple industrial sectors. We seek to partner with and acquire strategic interests in visionary companies that accelerate this mission. Xeriant is located at the Research Park at Florida Atlantic University in Boca Raton, Florida adjacent to the Boca Raton Airport.

For more information, please go to www.xeriant.com

SAFE HARBOR FORWARD-LOOKING STATEMENTS

In connection with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Xeriant, Inc. is hereby providing cautionary statements identifying important factors that could cause our actual results to differ materially from those projected in forward-looking statements (as defined in such act). Any statements that are not historical facts and that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, indicated through the use of words or phrases such as “will likely result,” “are expected to,” “will continue,” “is anticipated,” “estimated,” “intends,” “plans,” “believes” and “projects”) may be forward-looking and may involve estimates and uncertainties which could cause actual results to differ materially from those expressed in the forward-looking statements. These statements include, but are not limited to, our expectations concerning our ability to attract investors.

We caution that the factors described herein could cause actual results to differ materially from those expressed in any forward-looking statements we make, and investors should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time, and it is not possible for us to predict all such factors. Further, we cannot assess the impact of each such factor on our results of operations or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

This press release does not constitute an offer of any securities for sale.

Xeriant, Inc.
Investor Relations Dept.:
(561) 491-9595
IR@xeriant.com
www.xeriant.com


FAQ

What is the recent announcement by Xeriant, Inc. related to Next New Concept?

Xeriant signed a Letter of Intent with Next New Concept for the supply of up to $130 million of Retacell®-based wall panels for a residential project.

What is the estimated revenue from the Xeriant and Next New Concept agreement?

The agreement could generate over $250 million in revenue for Xeriant starting in 2023.

What are the applications of Retacell® used by Xeriant?

Retacell® is utilized for thermal and fire protection in wall panels and can be applied to various materials.

How many units are involved in the residential project with Next New Concept?

The project involves the construction of 35,000 residential units.

When is the residential development project with Next New Concept expected to be completed?

The project is anticipated to be completed within five years.

XERIANT INC

OTC:XERI

XERI Rankings

XERI Latest News

XERI Stock Data

7.66M
553.09M
6.08%
0.03%
Aerospace & Defense
Industrials
Link
United States of America
Boca Raton